Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Haroche

Showing results (11-20 of 285) with videos related to

Pageof 29
Sort By:
Annales D'Endocrinologie|May 13, 2017
Endocrine perturbations in POEMS syndrome: Misunderstood features of a rare paraneoplastic syndromeMaud Marchand, Julien Haroche, Philippe Touraine, et al.
Presse Medicale (Paris, France : 1983)|March 24, 2009
[Biotherapy of auto-immune diseases : past, present and future perspectives]Laurent Arnaud, Julien Haroche, Jean-Charles Piette, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2012
BRAF mutations in Erdheim-Chester diseaseJean-François Emile, Frédéric Charlotte, Zahir Amoura, et al.
Annals of the Rheumatic Diseases|January 22, 2020
Response to: 'Efficacy and improved tolerability of combination therapy with interleukin-1 blockade and MAPK pathway inhibitors for the treatment of Erdheim-Chester disease' by Campochiaro <i>et al</i>Fleur Cohen-Aubart, Neila Benameur, Zahir Amoura, et al.
Autoimmunity Reviews|August 23, 2011
Pathogenesis of Takayasu's arteritis: a 2011 updateLaurent Arnaud, Julien Haroche, Alexis Mathian, et al.
Autoimmunity Reviews|September 21, 2013
Pathogenesis of relapsing polychondritis: a 2013 updateLaurent Arnaud, Alexis Mathian, Julien Haroche, et al.
Lancet (London, England)|October 3, 2021
IgG4-related disease and Rosai-Dorfman-Destombes disease - Authors' replyJean-François Emile, Augusto Vaglio, Fleur Cohen-Aubart, et al.
British Journal of Haematology|November 13, 2024
Methotrexate and cytarabine in adult LCH: High risk, high reward and maintenance free?Jithma P Abeykoon, Ronald S Go, Levi-Dan Azoulay, et al.
Leukemia|June 28, 2020
Erdheim-Chester disease: a rapidly evolving disease modelFrancesco Pegoraro, Matthias Papo, Valerio Maniscalco, et al.
Travel Medicine and Infectious Disease|November 12, 2025
Rhino-orbital conidiobolomycosis in non-endemic Settings. A diagnostic and therapeutic challengeRomain Gueneau, Lei Tanaka, Pierre Reimbold, et al.
Pageof 29

Showing results (11-20 of 285) with videos related to

Sort By:
Pageof 29
Annales D'Endocrinologie|May 13, 2017
Endocrine perturbations in POEMS syndrome: Misunderstood features of a rare paraneoplastic syndromeMaud Marchand, Julien Haroche, Philippe Touraine, et al.
Presse Medicale (Paris, France : 1983)|March 24, 2009
[Biotherapy of auto-immune diseases : past, present and future perspectives]Laurent Arnaud, Julien Haroche, Jean-Charles Piette, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2012
BRAF mutations in Erdheim-Chester diseaseJean-François Emile, Frédéric Charlotte, Zahir Amoura, et al.
Annals of the Rheumatic Diseases|January 22, 2020
Response to: 'Efficacy and improved tolerability of combination therapy with interleukin-1 blockade and MAPK pathway inhibitors for the treatment of Erdheim-Chester disease' by Campochiaro <i>et al</i>Fleur Cohen-Aubart, Neila Benameur, Zahir Amoura, et al.
Autoimmunity Reviews|August 23, 2011
Pathogenesis of Takayasu's arteritis: a 2011 updateLaurent Arnaud, Julien Haroche, Alexis Mathian, et al.
Autoimmunity Reviews|September 21, 2013
Pathogenesis of relapsing polychondritis: a 2013 updateLaurent Arnaud, Alexis Mathian, Julien Haroche, et al.
Lancet (London, England)|October 3, 2021
IgG4-related disease and Rosai-Dorfman-Destombes disease - Authors' replyJean-François Emile, Augusto Vaglio, Fleur Cohen-Aubart, et al.
British Journal of Haematology|November 13, 2024
Methotrexate and cytarabine in adult LCH: High risk, high reward and maintenance free?Jithma P Abeykoon, Ronald S Go, Levi-Dan Azoulay, et al.
Leukemia|June 28, 2020
Erdheim-Chester disease: a rapidly evolving disease modelFrancesco Pegoraro, Matthias Papo, Valerio Maniscalco, et al.
Travel Medicine and Infectious Disease|November 12, 2025
Rhino-orbital conidiobolomycosis in non-endemic Settings. A diagnostic and therapeutic challengeRomain Gueneau, Lei Tanaka, Pierre Reimbold, et al.
Pageof 29